Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network-Reference-Cited by-同舟云学术

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network

Published:2018-04-19 Issue:6 Volume:181 Page:760-769
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Federico Massimo¹,Bellei Monica¹^ORCID,Marcheselli Luigi¹,Schwartz Marc²,Manni Martina¹,Tarantino Vittoria¹^ORCID,Pileri Stefano³⁴,Ko Young-Hyeh⁵,Cabrera Maria E.⁶,Horwitz Steven⁷,Kim Won S.⁸,Shustov Andrei⁹,Foss Francine M.¹⁰,Nagler Arnon¹¹,Carson Kenneth¹²,Pinter-Brown Lauren C.¹³,Montoto Silvia¹⁴,Spina Michele¹⁵,Feldman Tatyana A.¹⁶,Lechowicz Mary J.¹⁷,Smith Sonali M.¹⁸,Lansigan Frederick¹⁹,Gabus Raul²⁰,Vose Julie M.²¹,Advani Ranjana H.²²,

Affiliation:

1. Department of Diagnostic, Clinical and Public Health Medicine; University of Modena and Reggio Emilia; Modena Italy

2. MedNet Solutions; Minnetonka MN USA

3. IEO - Istituto Europeo di Oncologia; Unità di Diagnosi Emolinfopatologica; Milano Italy

4. Università degli Studi di Bologna, Scuola di Medicina e Chirurgia; Alma mater Professor of Pathology; Bologna Italy

5. Department of Pathology; Samsung Medical Centre; Sungkyunkwan University School of Medicine; Seoul South Korea

6. Hospital del Salvador; Universidad de Chile; Santiago Chile

7. Memorial Sloan-Kettering Cancer Center; New York NY USA

8. Division of Haematology-Oncology; Samsung Medical Centre; Sungkyunkwan University School of Medicine; Seoul South Korea

9. Fred Hutchinson Cancer Research Center; Seattle WA USA

10. Yale University School of Medicine; New Haven CT USA

11. Sheba Medical Centre; Tel Hashomer Israel

12. Washington University School of Medicine; St. Louis; MO USA

13. UCI; Irvine CA USA

14. Department of Haemato-Oncology; St. Bartholomew's Hospital; Barts Health NHS Trust; London UK

15. Medical Oncology A; National Cancer Institute; Aviano Italy

16. Hackensack University Medical Center; Hackensack NJ USA

17. Emory University; Atlanta GA USA

18. University of Chicago; Chicago IL USA

19. Dartmouth Hitchcock Medical Center; Hanover NH USA

20. Service of Haematology and Bone Marrow Transplantation; Hospital Maciel; Montevideo Uruguay

21. University of Nebraska Medical Center; UNMC, Internal Medicine; Omaha NE USA

22. Stanford University Medical Center; Stanford CA USA

Funder

Fondazione Cassa di Risparmio di Modena

Associazione Angela Serra per la Ricerca sul Cancro

Fondazione Italiana Linfomi

Allos Therapeutics

AIRC 5x1000

NIH/NCI CCSG

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15258/fullpdf

Reference32 articles.

1. A new look at the statistical model identification;Akaike;IEEE Transactions on Automatic Control,1974

2. T-cell lymphoma in South America and Europe;Bellei;Revista Brasileira de Hematologia e Hemoterapia,2012

3. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified;Beltran;Leukemia & Lymphoma,2016

4. Prognostic evaluation of neutrophil/lymphocyte ratio in patients with mycosis fungoides;Cengiz;Annals of Clinical and Laboratory Science,2017

5. Peripheral absolute neutrophil, mmonocyte and lymphocyte counts and clinical ooutcome in diffuse large B-cell lymphoma;Chen;Blood,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

2. Long‐term outcome of peripheral T‐cell lymphomas: Ten‐year follow‐up of the International Prospective T‐cell Project;British Journal of Haematology;2024-03-26

3. Intestinal T-cell lymphoma not otherwise specified: a case report and literature review;Future Science OA;2024-02-29

4. SOHO State-of-the-Art Updates and Next Questions: Treatment for Newly Diagnosed Peripheral T-Cell Lymphomas;Clinical Lymphoma Myeloma and Leukemia;2024-02

5. Impact of primary organ site of involvement by peripheral T‐cell lymphoma not otherwise specified on survival;Cancer Medicine;2023-12